The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by IoT solutions developer Samsara (IOT). 14 SPACs also went public. The pipeline got a boost, with six IPOs and three SPACs submitting...read more
Bionomics, an Australian Phase 2 biotech developing allosteric ion channel modulators for CNS disorders, raised $20 million by offering 1.6 million ADSs at $12.35, below the as-converted last close of its shares on the ASX ($15.66). Insiders had indicated on $15...read more
Bionomics, an Australian Phase 2 biotech developing allosteric ion channel modulators for CNS disorders, announced terms for its IPO on Monday. The Eastwood, Australia-based company plans to raise $25 million by offering 1.6 million ADSs at $15.45, the...read more
The IPO market got a break during the shortened holiday week, with just one IPO and six SPACs. New issuers continued to join the pipeline ahead of the final stretch of 2021, with seven IPOs and 17 SPACs submitting initial filings. Air purification company...read more
US IPO Weekly Recap: 6 IPOs debut ahead of the shortened holiday week
The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by IoT solutions developer Samsara (IOT). 14 SPACs also went public. The pipeline got a boost, with six IPOs and three SPACs submitting...read more
Australia-listed CNS biotech Bionomics prices US IPO at $12.35
Bionomics, an Australian Phase 2 biotech developing allosteric ion channel modulators for CNS disorders, raised $20 million by offering 1.6 million ADSs at $12.35, below the as-converted last close of its shares on the ASX ($15.66). Insiders had indicated on $15...read more
Australia-listed CNS biotech Bionomics sets terms for $25 million US IPO
Bionomics, an Australian Phase 2 biotech developing allosteric ion channel modulators for CNS disorders, announced terms for its IPO on Monday. The Eastwood, Australia-based company plans to raise $25 million by offering 1.6 million ADSs at $15.45, the...read more
US IPO Weekly Recap: The shortened holiday week brings just 1 IPO
The IPO market got a break during the shortened holiday week, with just one IPO and six SPACs. New issuers continued to join the pipeline ahead of the final stretch of 2021, with seven IPOs and 17 SPACs submitting initial filings. Air purification company...read more